Filing Flows › Shattuck Labs (STTK) › Recalls, complaints & regulation
Shattuck Labs (STTK): clinical trials
Shattuck Labs (STTK) beyond its filings: 2 active clinical trials.
Shattuck Labs' latest quarter
Shattuck Labs, Q3 2025: revenue $1.0M (-67% year over year), net loss $10.1M, operating cash flow −$8.9M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Shattuck Labs have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.